Leucid Bio

News

CAR-T therapies have revolutionised the treatment of some blood cancers, but so far haven't been able to repeat that success in solid tumours.

News

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.